Interferon lambada-antibody complexes
The present invention concerns methods and compositions for forming complexes of interferon-λ with an antibody or antigen-binding antibody fragment. In preferred embodiments, the interferon-λ and the antibody or fragment are fusion proteins, each comprising a dimerization and docking domain (DDD) moiety from human protein kinase A or an anchor domain (AD) moiety from an A-kinase anchoring protein (AKAP). In more preferred embodiments, the interferon-antibody complex is more efficacious for treatment of cancer, asthma, Alzheimer's disease, multiple sclerosis or viral infection than interferon-λ alone, antibody alone, or the combination of unconjugated interferon-λ and antibody.
IBC Pharmaceuticals, Inc.
A C C C G C C C C C C C C C A C C C C A A C B C C A C C A A C C A C C A A C A C A C A A A A C C C A A A C
A61K C07K C07K C07K G01N C07K C07K C07K C07K C07K C07K C07K C07K C07K A61K C07K C07K C07K C07K A61K A61K C07K B82Y C07K C07K A61K C07K C07K A61K A61K C07K C07K A61K C07K C07K A61K A61K C07K A61K C07K A61K C07K A61K A61K A61K A61K C07K C07K C07K A61K A61K A61K C07K
inventional inventional inventional additional inventional additional additional additional additional additional additional inventional inventional inventional inventional additional additional inventional additional inventional inventional inventional additional additional additional additional inventional additional inventional inventional inventional inventional inventional inventional additional inventional inventional additional inventional inventional inventional additional inventional inventional inventional inventional inventional inventional additional inventional inventional inventional inventional
Donglin David M. Chien-Hsing
Liu Goldenberg Chang